Table 4 Changes in oral manifestations between the first and second study stages
From: Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
Stage 1 | Stage 2 | Kappa | P value | McNemar P value | ||
|---|---|---|---|---|---|---|
Yes | No | |||||
Mucositis | Yes | 0 | 2 | −0.077 | 0.999 | 0.109 |
No | 8 | 35 | ||||
Xerostomia | Yes | 2 | 5 | 0.369 | 0.065 | 0.063 |
No | 0 | 19 | ||||
Cold sores | Yes | 0 | 1 | −0.023 | 0.999 | 0.999 |
No | 1 | 43 | ||||
Candidiasis | Yes | 2 | 0 | 0.646 | 0.006 | 0.500 |
No | 2 | 41 | ||||